Mesenchymal tumor cells drive adaptive resistance of Trp53 −/− breast tumor cells to inactivated mutant Kras-Reference-Cited by-同舟云学术

Mesenchymal tumor cells drive adaptive resistance of Trp53 ^−/− breast tumor cells to inactivated mutant Kras

Published:2022-04-23 Issue:17 Volume:16 Page:3128-3145
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

van Weele Linda J.¹^ORCID,Djomehri Sabra I.¹,Cai Shang¹,Antony Jane¹,Sikandar Shaheen S.¹,Qian Dalong¹,Ho William H. D.¹²,West Robert B.³,Scheeren Ferenc A.⁴,Clarke Michael F.¹

Affiliation:

1. Institute for Stem Cell Biology and Regenerative Medicine School of Medicine Stanford University CA USA

2. Department of Stem Cell Biotechnology California State University Channel Islands Camarillo CA USA

3. Department Pathology Stanford University Medical Center Palo Alto CA USA

4. Department of Medical Oncology Leiden University Medical Center The Netherlands

Funder

U.S. Department of Defense

California Institute for Regenerative Medicine

Breast Cancer Research Foundation

Ludwig Institute for Cancer Research

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13220

Reference98 articles.

1. Comprehensive Characterization of Cancer Driver Genes and Mutations

2. Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells

3. Comprehensive molecular portraits of human breast tumours

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination;Cellular Oncology;2023-02-03